200 related articles for article (PubMed ID: 31473306)
1. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
2. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
3. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
4. Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.
Meyer AR; Engevik AC; Willet SG; Williams JA; Zou Y; Massion PP; Mills JC; Choi E; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2019; 8(3):379-405. PubMed ID: 31071489
[TBL] [Abstract][Full Text] [Related]
5. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
[TBL] [Abstract][Full Text] [Related]
6. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
7. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
9. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
10. Mature gastric chief cells are not required for the development of metaplasia.
Kinoshita H; Hayakawa Y; Niu Z; Konishi M; Hata M; Tsuboi M; Hayata Y; Hikiba Y; Ihara S; Nakagawa H; Hirata Y; Wang TC; Koike K
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G583-G596. PubMed ID: 29345968
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Radyk MD; Burclaff J; Willet SG; Mills JC
Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
[TBL] [Abstract][Full Text] [Related]
12. GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.
Hata M; Kinoshita H; Hayakawa Y; Konishi M; Tsuboi M; Oya Y; Kurokawa K; Hayata Y; Nakagawa H; Tateishi K; Fujiwara H; Hirata Y; Worthley DL; Muranishi Y; Furukawa T; Kon S; Tomita H; Wang TC; Koike K
Gastroenterology; 2020 May; 158(6):1650-1666.e15. PubMed ID: 32032583
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
14. Oxyntic atrophy, metaplasia, and gastric cancer.
Goldenring JR; Nam KT
Prog Mol Biol Transl Sci; 2010; 96():117-31. PubMed ID: 21075342
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
16. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
[TBL] [Abstract][Full Text] [Related]
17. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
18. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
20. The origin of pre-neoplastic metaplasia in the stomach: chief cells emerge from the Mist.
Goldenring JR; Nam KT; Mills JC
Exp Cell Res; 2011 Nov; 317(19):2759-64. PubMed ID: 21907708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
